Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
53 hedge funds and large institutions have $406M invested in Vicarious Surgical in 2021 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 12 closing their positions.
475% more call options, than puts
Call options by funds: $31M | Put options by funds: $5.39M
150% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 12
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
51% more funds holding
Funds holding: 35 → 53 (+18)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
8% more capital invested
Capital invested by funds: $376M → $406M (+$30M)
1.43% less ownership
Funds ownership: 2.56% → 1.13% (-1.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$18.4M |
| 2 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$12.6M |
| 3 |
BlackRock
New York
|
+$9.58M |
| 4 |
Legal & General Group
London,
United Kingdom
|
+$9.51M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$2.32M |
| 2 |
GCM
Ghisallo Capital Management
Boston,
Massachusetts
|
-$1.5M |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.08M |
| 4 |
HF
HRT Financial
New York
|
-$1.02M |
| 5 |
Morgan Stanley
New York
|
-$828K |
RBOT Hedge Fund Activity: Q4 2021 in Review
53 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2021, worth a combined $406M — up 8% from $376M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new RBOT positions and 12 closed out — a net gain of 18 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $18.4M. The largest seller was Parian Global Management, exiting entirely with an estimated $2.32M sold.
- 53 institutional investors held Vicarious Surgical (RBOT) as of Q4 2021, up from 35 in Q3 2021.
- Funds reported $406M of Vicarious Surgical stock for Q4 2021, up 8% quarter-over-quarter.
- 30 funds opened new Vicarious Surgical positions in Q4 2021 and 12 closed out, a net change of +18 holders.
- The largest Vicarious Surgical buyer in Q4 2021 was Vanguard Group, an estimated $18.4M added.
- The largest Vicarious Surgical seller in Q4 2021 was Parian Global Management, an estimated $2.32M sold.
Based on aggregated 13F filings for Q4 2021.